PIP4K2B

Phosphatidylinositol-5-phosphate 4-kinase type 2 beta P78356 PI42B_HUMAN
Protein Coding Chr 17 17q12 Swiss-Prot reviewed Entrez 8396
Mutations
36
CL 20 · Tissue 0
Samples
25
CL 17 · Tissue 0
Peptides
36
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations36200
Samples25170
Peptides36200

Function

PIP4K2B · Phosphatidylinositol-5-phosphate 4-kinase type 2 beta

The protein encoded by this gene catalyzes the phosphorylation of phosphatidylinositol-5-phosphate on the fourth hydroxyl of the myo-inositol ring to form phosphatidylinositol-5,4-bisphosphate. This gene is a member of the phosphatidylinositol-5-phosphate 4-kinase family. The encoded protein sequence does not show similarity to other kinases, but the protein does exhibit kinase activity. Additionally, the encoded protein interacts with p55 TNF receptor. [provided by RefSeq, Jul 2008].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000619039 P78356 36 36

Gene Properties

Type
Protein Coding
Chromosome
17
Cytoband
17q12
Entrez ID
Aliases
PI5P4KBPIP5K2BPIP5KIIBPIP5KIIbetaPIP5P4KB

Recurrent Mutations

All 36 amino-acid changes on canonical ENST00000619039 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in PIP4K2B · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in PIP4K2B – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Lymphoblastic Leukemia
1/40 2%
0/0 0%
Endometrial Carcinoma
2/42 5%
1/612 0%
Ovarian Carcinoma
3/109 3%
1/998 0%
Neuroendocrine Tumour
1/154 1%
0/577 0%
Colorectal Carcinoma
3/143 2%
1/3239 0%
Gastric Carcinoma
1/74 1%
1/1809 0%
Biliary Tract Carcinoma
1/54 2%
0/950 0%
Bladder Carcinoma
0/58 0%
1/956 0%
Prostate Carcinoma
1/13 8%
1/2105 0%
Head and Neck Carcinoma
0/85 0%
1/1574 0%
Pancreatic Carcinoma
1/89 1%
0/1611 0%
Breast Carcinoma
2/144 1%
0/3264 0%
Hepatocellular Carcinoma
0/46 0%
1/2210 0%
Esophageal Squamous Cell Carcinoma
1/51 2%
0/2550 0%

Mutation Distribution

Where PIP4K2B is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in PIP4K2B were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 54 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 36 mutations in PIP4K2B

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide